Systemic therapy for advanced soft tissue sarcomas: highlighting novel therapies and treatment approaches.
Journal Information
Full Title: Cancer
Abbreviation: Cancer
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"CONFLICT OF INTEREST DISCLOSURES Dr. Riedel has received clinical research support from Novartis Pharmaceuticals, ARIAD Pharmaceuticals, and Ziopharm Oncology and an honorarium from ARIAD Pharmaceuticals. He is also a consultant for Merck & Co. Inc, and has served on speakers bureaus for both Novartis and Pfizer, Inc."
Funding Disclosure
Evidence found in paper:
"FUNDING SUPPORT"
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025